To identify the mechanism behind the analgesic effects of GLP-1 analogs and exendin 939, we utilized a cell line lacking GLP-1R to transfect the rat TRPV1 plasmid
Additionally, exendin 939 administration mitigated paw swelling resulting from CFA induction (Supplementary Fig
Approximately 0.1% of GLP-1 users report pancreatitis during clinical trials, though causality remains debated among researchers
This allows pharmaceutical companies to reduce their environmental footprint with minimal operational impact, a growing priority as sustainability regulations become increasingly stringent
Tirzepatide (Zepbound) became the first pharmacologic therapy approved for moderate-to-severe obstructive sleep apnea in adults with obesity, after a major trial showed it significantly reduced breathing interruptions during sleep, both in people using CPAP machines and those who weren't
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the food and drug administration adverse event reporting system (FAERS)
![Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3678716518672074937)
